Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Catherine Derington

Concepts (157)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antihypertensive Agents
32
2026
519
7.500
Why?
Hypertension
33
2026
1272
6.730
Why?
Blood Pressure
25
2026
1765
3.160
Why?
Angiotensin Receptor Antagonists
7
2026
115
1.960
Why?
Angiotensin-Converting Enzyme Inhibitors
6
2026
228
1.880
Why?
Veterans
10
2026
1650
1.530
Why?
Adrenergic beta-Antagonists
4
2026
253
1.110
Why?
Cardiovascular Diseases
11
2026
2219
1.090
Why?
Dementia
4
2025
324
1.040
Why?
Atherosclerosis
4
2023
410
0.930
Why?
Liraglutide
1
2025
32
0.900
Why?
Immunoglobulin Fc Fragments
1
2025
41
0.890
Why?
Primary Prevention
3
2025
222
0.870
Why?
Aged
37
2026
26432
0.860
Why?
Authorship
1
2025
51
0.840
Why?
Glucagon-Like Peptides
1
2025
76
0.800
Why?
Cognitive Dysfunction
3
2025
481
0.800
Why?
Publishing
1
2025
117
0.790
Why?
Empathy
1
2025
184
0.740
Why?
Recombinant Fusion Proteins
1
2025
663
0.740
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2024
449
0.710
Why?
Hypoglycemic Agents
3
2025
1412
0.680
Why?
Losartan
1
2020
13
0.650
Why?
Atrial Fibrillation
2
2026
560
0.650
Why?
Lisinopril
1
2020
15
0.650
Why?
Nutrition Surveys
7
2023
270
0.650
Why?
Angioedema
1
2020
16
0.640
Why?
United States
23
2026
16136
0.630
Why?
Hypercholesterolemia
1
2021
95
0.620
Why?
Naloxone
1
2020
139
0.590
Why?
Medication Adherence
7
2026
535
0.570
Why?
Diabetes Mellitus, Type 2
4
2026
2623
0.570
Why?
Middle Aged
27
2026
36619
0.560
Why?
Elective Surgical Procedures
1
2020
216
0.550
Why?
Humans
57
2026
146342
0.530
Why?
Male
36
2026
73396
0.520
Why?
Female
36
2026
79499
0.490
Why?
Heart Diseases
1
2020
343
0.490
Why?
Drug Overdose
1
2020
377
0.460
Why?
Stroke
2
2026
1287
0.440
Why?
Antibodies, Monoclonal, Humanized
1
2021
992
0.430
Why?
Insulin Glargine
2
2025
88
0.420
Why?
Percutaneous Coronary Intervention
1
2020
550
0.410
Why?
Cross-Sectional Studies
11
2026
5899
0.380
Why?
Retrospective Studies
10
2026
17438
0.350
Why?
Cardiology
2
2026
363
0.340
Why?
Cost-Benefit Analysis
4
2023
640
0.340
Why?
Risk Factors
10
2026
10921
0.310
Why?
Anticholesteremic Agents
2
2022
156
0.310
Why?
Drug Therapy, Combination
5
2026
1036
0.300
Why?
Healthcare Disparities
3
2026
733
0.300
Why?
Adult
17
2026
41087
0.290
Why?
Mineralocorticoid Receptor Antagonists
2
2026
69
0.270
Why?
Drug Combinations
4
2023
400
0.260
Why?
Drug Costs
2
2026
116
0.260
Why?
United States Department of Veterans Affairs
3
2026
777
0.240
Why?
Practice Patterns, Physicians'
2
2026
1408
0.230
Why?
Follow-Up Studies
5
2022
5439
0.230
Why?
Rural Health
1
2026
87
0.230
Why?
Stroke Volume
2
2026
652
0.230
Why?
Cholesterol, LDL
3
2024
363
0.230
Why?
Drug Resistance
1
2026
145
0.220
Why?
Eicosapentaenoic Acid
2
2023
37
0.220
Why?
Sodium
1
2026
196
0.220
Why?
Ezetimibe
2
2022
24
0.220
Why?
Treatment Outcome
6
2026
11821
0.210
Why?
Aged, 80 and over
6
2026
8391
0.210
Why?
Grief
1
2025
52
0.210
Why?
Databases, Factual
2
2020
1493
0.210
Why?
Comparative Effectiveness Research
1
2025
171
0.210
Why?
Health Expenditures
1
2026
198
0.210
Why?
Myocardial Infarction
2
2022
1215
0.210
Why?
Glucagon-Like Peptide 1
1
2025
150
0.200
Why?
Risk Reduction Behavior
1
2026
220
0.200
Why?
Renal Insufficiency
1
2026
173
0.200
Why?
Proportional Hazards Models
3
2022
1331
0.200
Why?
Health Care Costs
2
2024
423
0.200
Why?
Time-to-Treatment
1
2026
257
0.200
Why?
Pharmacies
1
2024
40
0.200
Why?
Pharmacy
1
2024
32
0.200
Why?
Quality Indicators, Health Care
1
2026
343
0.200
Why?
Text Messaging
1
2026
188
0.190
Why?
Thiazides
1
2022
1
0.190
Why?
Gastrointestinal Diseases
1
2025
220
0.190
Why?
Drug Monitoring
1
2026
399
0.180
Why?
Receptor, Angiotensin, Type 2
1
2022
8
0.180
Why?
Receptor, Angiotensin, Type 1
1
2022
25
0.180
Why?
Warfarin
1
2023
179
0.170
Why?
Calcium Channel Blockers
1
2022
165
0.170
Why?
Heart Failure
2
2026
2329
0.170
Why?
Anticoagulants
2
2026
746
0.170
Why?
Hyperlipidemias
1
2022
120
0.170
Why?
Rural Population
1
2026
677
0.160
Why?
Proprotein Convertase 9
1
2021
88
0.160
Why?
Social Determinants of Health
1
2024
317
0.160
Why?
Health Behavior
1
2026
802
0.150
Why?
Data Mining
1
2020
113
0.150
Why?
Hospitalization
2
2021
2475
0.150
Why?
Frailty
1
2023
208
0.150
Why?
Angina, Stable
1
2019
18
0.150
Why?
Costs and Cost Analysis
1
2020
217
0.150
Why?
Propensity Score
1
2021
376
0.140
Why?
Drug Administration Schedule
1
2020
790
0.140
Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
266
0.140
Why?
Risk Assessment
2
2025
3712
0.140
Why?
Coronary Angiography
1
2020
325
0.130
Why?
Goals
1
2019
187
0.130
Why?
Veterans Health
1
2019
188
0.130
Why?
Exercise Test
1
2020
637
0.120
Why?
Patient Selection
1
2021
728
0.120
Why?
Randomized Controlled Trials as Topic
2
2022
1763
0.120
Why?
Dose-Response Relationship, Drug
1
2020
2022
0.120
Why?
Survival Rate
1
2021
2092
0.120
Why?
Decision Support Systems, Clinical
1
2020
279
0.120
Why?
Sex Characteristics
1
2021
801
0.110
Why?
Electronic Health Records
2
2020
1210
0.110
Why?
Cohort Studies
2
2023
6077
0.110
Why?
Coronary Artery Disease
1
2021
751
0.110
Why?
American Heart Association
2
2026
364
0.110
Why?
Time Factors
2
2026
7109
0.100
Why?
Biomarkers
2
2026
4340
0.100
Why?
Patient Care Team
1
2019
701
0.100
Why?
Health Personnel
1
2020
754
0.100
Why?
Case-Control Studies
1
2021
3647
0.100
Why?
Patient Acceptance of Health Care
1
2019
881
0.090
Why?
Algorithms
1
2020
1849
0.090
Why?
Prevalence
3
2023
2861
0.080
Why?
Primary Health Care
1
2020
1776
0.070
Why?
Incidence
2
2026
2936
0.060
Why?
Practice Guidelines as Topic
2
2024
1591
0.060
Why?
Mississippi
1
2026
34
0.060
Why?
Anti-Arrhythmia Agents
1
2026
144
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2026
135
0.060
Why?
Adolescent
2
2026
22557
0.050
Why?
California
1
2026
475
0.050
Why?
Medicare Part D
1
2024
23
0.050
Why?
Multicenter Studies as Topic
1
2026
417
0.050
Why?
Health Literacy
1
2026
183
0.050
Why?
Quality-Adjusted Life Years
1
2023
122
0.050
Why?
Renin-Angiotensin System
1
2023
80
0.050
Why?
Drug Prescriptions
1
2024
314
0.040
Why?
Guideline Adherence
1
2026
594
0.040
Why?
Metformin
1
2025
328
0.040
Why?
Evaluation Studies as Topic
1
2020
161
0.040
Why?
Self Report
1
2024
870
0.040
Why?
Health Status Disparities
1
2022
322
0.030
Why?
Health Services Accessibility
1
2026
1107
0.030
Why?
Antiviral Agents
1
2023
779
0.030
Why?
Quality Improvement
1
2026
1354
0.030
Why?
Medicare
1
2023
920
0.030
Why?
Young Adult
2
2026
14330
0.030
Why?
Telemedicine
1
2026
966
0.030
Why?
Registries
1
2024
2400
0.030
Why?
Cognition
1
2023
1292
0.030
Why?
Pandemics
1
2023
1707
0.030
Why?
Aging
1
2024
1996
0.020
Why?
Severity of Illness Index
1
2019
2921
0.020
Why?
Derington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)